Viewing Study NCT04640168


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2025-12-29 @ 2:51 PM
Study NCT ID: NCT04640168
Status: COMPLETED
Last Update Posted: 2022-06-28
First Post: 2020-11-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ACTT View
None Adaptive View
None COVID-19 View
None Efficacy View
None Multicenter View
None novel coronavirus View
None Safety View